Letter by Ahmed et al Regarding Article, "Low-Dose Aspirin for Primary Prevention of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus: 10-Year Follow-Up of a Randomized Controlled Trial". Issue 18 (2nd May 2017)